BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Artenie A, Luhmann N, Lim AG, Fraser H, Ward Z, Stone J, Macgregor L, Walker JG, Trickey A, Marquez LK, Abu-raddad LJ, Ayoub HH, Walsh N, Hickman M, Martin NK, Easterbrook P, Vickerman P. Methods and indicators to validate country reductions in incidence of hepatitis C virus infection to elimination levels set by WHO. The Lancet Gastroenterology & Hepatology 2022. [DOI: 10.1016/s2468-1253(21)00311-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Robinson E, Byrne CJ, Carberry J, Radley A, Beer LJ, Inglis SK, Tait J, Macpherson I, Goldberg D, Hutchinson SJ, Hickman M, Dillon JF. Laying the foundations for hepatitis C elimination: evaluating the development and contribution of community care pathways to diagnostic efforts. BMC Public Health 2023;23:54. [PMID: 36611156 DOI: 10.1186/s12889-022-14911-1] [Reference Citation Analysis]
2 van Santen DK, Sacks-Davis R, Stewart A, Boyd A, Young J, van der Valk M, Smit C, Rauch A, Braun DL, Jarrin I, Berenguer J, Lazarus JV, Lacombe K, Requena MB, Wittkop L, Leleux O, Salmon D, Bonnet F, Matthews G, Doyle JS, Spelman T, Klein MB, Prins M, Asselin J, Stoové MA, Hellard M; InCHEHC study group. Treatment as prevention effect of direct-acting antivirals on primary hepatitis C virus incidence: Findings from a multinational cohort between 2010 and 2019. EClinicalMedicine 2023;56:101810. [PMID: 36618902 DOI: 10.1016/j.eclinm.2022.101810] [Reference Citation Analysis]
3 Siegele-Brown C, Siegele-Brown M, Cook C, Khakoo SI, Parkes J, Wright M, Buchanan RM. Testing to sustain hepatitis C elimination targets in people who inject drugs: A network-based model. J Viral Hepat 2022. [PMID: 36529668 DOI: 10.1111/jvh.13786] [Reference Citation Analysis]
4 Iversen J, Wand H, McManus H, Dore GJ, Maher L. Incidence of primary hepatitis C virus infection among people who inject drugs in Australia pre- and post-unrestricted availability of direct acting antiviral therapies. Addiction 2022. [PMID: 36524842 DOI: 10.1111/add.16113] [Reference Citation Analysis]
5 Buti M, Craxi A, Foster GR, Maticic M, Negro F, Zeuzem S, Zoulim F. Viral hepatitis elimination: Towards a hepatitis-free world. J Hepatol 2022;77:1444-7. [PMID: 35907517 DOI: 10.1016/j.jhep.2022.06.034] [Reference Citation Analysis]
6 Pourkarim M, Nayebzadeh S, Alavian SM, Hataminasab SH. Digital Marketing: A Unique Multidisciplinary Approach towards the Elimination of Viral Hepatitis. Pathogens 2022;11:626. [DOI: 10.3390/pathogens11060626] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]